Patents by Inventor Paul Francis Cavanaugh, Jr.

Paul Francis Cavanaugh, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oligonucleotide analogues containing phosphate diester linkage substitutes, compositions thereof, and precursor dinucleotide analogues
    Patent number: 5677439
    Abstract: The present invention relates to compounds, compositions and methods for inhibiting gene expression. The compounds of this invention comprise 1) oligonucleoside sequences of from about 6 to about 200 bases having a three atom internucleoside linkage or 2) oligonucleotide sequences of from about 9 to about 200 bases having a diol at either or both termini.
    Type: Grant
    Filed: May 24, 1995
    Date of Patent: October 14, 1997
    Assignee: Sanofi
    Inventors: Alexander Ludvik Weis, Frederick Herman Hausheer, Prasad Venkata Chala Chaturvedula, Daniel Joseph Delecki, Paul Francis Cavanaugh, Jr., Patricia Susan Moskwa, Fred Terry Oakes
  • Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
    Patent number: RE36419
    Abstract: The present invention provides novel methods for prevention or treatment of primary and recurring squamous cell carcinoma of the oral cavity or oropharynx comprising topical administration, to the oral cavity or oropharynx, of an effective amount of an NSAID, especially a composition administering from about 0.001% to about 0.2% ketorolac to the oral cavity, alone or as an adjunct to surgery and/or radiation therapy.
    Type: Grant
    Filed: March 27, 1998
    Date of Patent: November 30, 1999
    Assignee: The Procter & Gamble Company
    Inventor: Paul Francis Cavanaugh, Jr.